• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday

    9/12/22 3:23:40 AM ET
    $ADTX
    $AHI
    $AKRO
    $ALEC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $ADTX alert in real time by email

    Gainers

    • Digital Media Solutions, Inc. (NYSE:DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) climbed 50.5% to close at $1.64.
    • Aditxt, Inc. (NASDAQ:ADTX) gained 37% to close at $0.1918.
    • Trinity Place Holdings Inc. (NYSE:TPHS) surged 33.8% to settle at $1.10.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 31.1% to close at $0.2197. Shares of tech companies traded higher as stocks rebound following recent weakness.
    • MOGU Inc. (NYSE:MOGU) shares gained 29.8% to close at $2.60 after the company announced a $10 million repurchase program.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) gained 26.1% to close at $38.80.
    • Annovis Bio, Inc. (NASDAQ:ANVS) surged 25.5% to close at $15.30.
    • Invitae Corporation (NYSE:NVTA) jumped 25% to close at $4.00.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) shares jumped 24.2% to close at $11.02 after the company issued an update on its research/development and commercial activities.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) gained 22.8% to close at $2.75.
    • Veru Inc. (NASDAQ:VERU) rose 21.9% to settle at $15.57. The FDA recently scheduled an Oct. 6 adcomm meeting for Emergency Use Authorization of sabizabulin for hospitalized COVID-19 patients at high risk for ARDS.
    • Zscaler, Inc. (NASDAQ:ZS) surged 21.9% to close at $188.00 after the company reported better-than-expected Q4 results and issued sales guidance above estimates.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 21.6% to close at $1.11.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) gained 20.9% to close at $5.27. Terns Pharmaceuticals’ 10% owner Vivo Capital Surplus Fund VIII, L.P. acquired a total of 600,000 shares at an average price of $3.60.
    • ProKidney Corp. (NASDAQ:PROK) jumped 20.4% to settle at $9.84.
    • Biodesix, Inc. (NASDAQ:BDSX) gained 19.6% to close at $1.83. The company, last month, posted upbeat quarterly results.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) rose 17.4% to close at $0.6449.
    • eFFECTOR Therapeutics recently filed for mixed-securities shelf offering of up to $200 million.
    • IperionX Limited (NASDAQ:IPX) jumped 17.2% to close at $7.30.
    • WeTrade Group, Inc. (NASDAQ:WETG) rose 16.9% to close at $1.59.
    • Yiren Digital Ltd. (NYSE:YRD) gained 16.5% to close at $1.20. Yiren Digital recently announced up to $20 million buyback program.
    • TDH Holdings, Inc. (NASDAQ:PETZ) surged 16.4% to close at $4.34.
    • Forge Global Holdings, Inc. (NYSE:FRGE) jumped 16.2% to close at $4.38.
    • (NASDAQ:KTRA) gained 15.5% to close at $0.1686. Kintara Therapeutics, last month, said it entered into an equity purchase agreement with Lincoln Park Capital for up to $20 million.
    • Scienjoy Holding Corporation (NASDAQ:SJ) surged 15.4% to settle at $4.50.
    • fuboTV Inc. (NASDAQ:FUBO) jumped 15.1% to close at $4.43.
    • Aravive, Inc. (NASDAQ:ARAV) gained 14.4% to close at $0.89. Aravive, last month, posted a Q2 loss of $0.61 per share.
    • Torrid Holdings Inc. (NASDAQ:CURV) surged 14.4% to close at $6.50.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) gained 14.1% to close at $1.94.
    • Kalera Public Limited Company (NASDAQ:KAL) jumped 13.8% to close at $2.22.
    • Poshmark, Inc. (NASDAQ:POSH) surged 13.8% to close at $12.93.
    • SharpLink Gaming Ltd. (NASDAQ:SBET) rose 13.6% to close at $1.17. SharpLink Gaming recently announced plans to acquire SportsHub Games Network.
    • The RealReal, Inc. (NASDAQ:REAL) gained 13.6% to close at $2.43.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) jumped 13.6% to settle at $9.27.
    • Peloton Interactive, Inc. (NASDAQ:PTON) rose 13.3% to close at $10.31.
    • iMedia Brands, Inc. (NASDAQ:IMBI) gained 13% to settle at $0.97. The company recently posted downbeat quarterly results.
    • Warby Parker Inc. (NASDAQ:WRBY) surged 12.9% to close at $15.96.
    • Zai Lab Limited (NASDAQ:ZLAB) shares rose 12.6% to close at $48.80.
    • RenovoRx, Inc. (NASDAQ:RNXT) climbed 12.5% to settle at $2.79.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) gained 12.5% to close at $9.72 as the stock was mentioned as a potential short squeeze name on social media.
    • AxoGen, Inc. (NASDAQ:AXGN) rose 12.5% to close at $11.49. Axogen, last month, posted a Q2 loss of $0.06 per share.
    • Borr Drilling Limited (NYSE:BORR) gained 12.1% to close at $4.18.
    • Osisko Development Corp. (NYSE:ODV) gained 11.4% to settle at $5.76.
    • FuelCell Energy, Inc. (NASDAQ:FCEL) rose 11.3% to close at $4.24. The stock may be rebounding after falling Thursday following a wider-than-expected Q3 net loss.
    • Riot Blockchain, Inc. (NASDAQ:RIOT) gained 10.7% to close at $8.26 amid a rise in Bitcoin and Ethereum prices.
    • Coinbase Global, Inc. (NASDAQ:COIN) rose 10.7% to close at $80.87 amid an increase in the price of Bitcoin and Ethereum. Also, Daiwa Capital upgraded the stock from Outperform to Buy and maintained a $100 price target.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) climbed 10.6% to close at $5.11 after gaining 7% on Thursday.
    • DocuSign, Inc. (NASDAQ:DOCU) climbed 10.5% to close at $64.04 after the company reported better-than-expected Q2 results.
    • Bausch Health Companies Inc. (NYSE:BHC) rose 10.5% to close at $7.40 after the stock fell Thursday following tentative FDA approval for a generic competitor fo the company's Xifaxan. Bausch noted its patent protection for Xifaxan will last until 2029.
    • Stronghold Digital Mining, Inc. (NASDAQ:SDIG) gained 10.3% to close at $1.61 after gaining over 7% on Thursday.
    • Core Scientific, Inc. (NASDAQ:CORZ) gained 9.2% to close at $2.26. The company, last month, posted upbeat quarterly sales.
    • The Kroger Co. (NYSE:KR) gained 7.4% to close at $51.94 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 guidance.
    • RLX Technology Inc. (NYSE:RLX) gained 6.2% to close at $1.37.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) gained 4.8% to close at $0.1782 after the company announced a review of strategic alternatives.

     

    Losers

    • Immunocore Holdings plc (NASDAQ:IMCR) shares dipped 22.1% to close at $44.75 on Friday after the company presented its Phase 1 data for TCR therapy targeting PRAME.
    • Troika Media Group, Inc. (NASDAQ:TRKA) dropped 17.2% to close at $0.3975.
    • Avaya Holdings Corp. (NYSE:AVYA) fell 15.7% to close at $1.56.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 15.5% to close at $0.81.
    • CleanTech Acquisition Corp. (NASDAQ:CLAQ) dropped 15.3% to close at $6.10.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) fell 15.1% to close at $4.78.
    • eGain Corporation (NASDAQ:EGAN) dropped 14.3% to close at $7.57 after the company issued FY23 EPS and sales guidance below analyst estimates.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) fell 13.7% to close at $0.68.
    • TPI Composites, Inc. (NASDAQ:TPIC) fell 13.5% to close at $16.31.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) dropped 13.2% to close at $1.12. Morgan Stanley maintained Rubius Therapeutics with an Equal-Weight and lowered the price target from $2 to $1.5.
    • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) fell 13% to close at $0.1796. NovaBay Pharmaceuticals entered into agreements for a private placement and warrant reprice transactions to raise up to $5.3 million.
    • Alector, Inc. (NASDAQ:ALEC) dropped 12.4% to close at $9.62 after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and lowered its price target from $27 to $13.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) fell 11.2% to close at $11.71.
    • VirnetX Holding Corp (NYSE:VHC) declined 10.9% to close at $1.39.
    • GigaCloud Technology Inc. (NASDAQ:GCT) fell 9.9% to close at $18.10.
    • Biophytis S.A. (NASDAQ:BPTS) dropped 9.5% to close at $0.8244. Biophytis recently announced top-line results from its phase 2-3 COVA clinical study evaluating Sarconeos in the treatment of COVID-19-related respiratory failure.
    • Mullen Automotive, Inc. (NASDAQ:MULN) fell 7.6% to close at $0.5638. Mullen Automotive recently acquired a controlling interest in EV truck innovator Bollinger Motors Inc.
    • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) dropped 6.3% to close at $12.58 after the company reported worse-than-expected Q1 EPS and sales results.
    • Enphase Energy, Inc. (NASDAQ:ENPH) declined 3.7% to close at $305.70 after Guggeheim downgraded the stock from Buy to Neutral.
    Get the next $ADTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $AHI
    $AKRO
    $ALEC

    CompanyDatePrice TargetRatingAnalyst
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update

    -The first 4 Patients enrolled into Cohort 1 of the BB-301 Phase 1b/2a treatment study have completed the 12-month statistical follow-up period, and all 4 Completers were formal Responders to BB-301 at the 12-month follow-up timepoint demonstrating durable response to BB-301- -Patient 1 of Cohort 1 completed the 24-month follow-up timepoint, and at the 24-month post-treatment timepoint Patient 1 continued to experience the disease-modifying effects of BB-301, with deepening improvements in post-swallow residue and total dysphagic symptom burden as compared to the 12-month follow-up timepoint- - An update on the Interim clinical results for Cohort 2 is planned for mid-2026- -FDA meeting to

    2/12/26 8:30:00 AM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer's Disease

    MALVERN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced that an independent Data and Safety Monitoring Board (DSMB) has issued a positive recommendation regarding the safety of buntanetap at 6 months, supporting the continuation of the ongoing pivotal Phase 3 AD clinical trial without modification. The DSMB is responsible for periodically reviewing accumulated safety data and providing independent recommendations on the conduct

    2/12/26 8:00:00 AM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Emeritus Director Schuler Jack W bought $1,180,736 worth of shares (100,000 units at $11.81) (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    1/27/26 9:29:02 AM ET
    $BDSX
    Medical Specialities
    Health Care

    Emeritus Director Schuler Jack W bought $903,561 worth of shares (82,465 units at $10.96) (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    1/26/26 9:28:57 AM ET
    $BDSX
    Medical Specialities
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Appio Thomas was granted 1,137,862 shares, increasing direct ownership by 64% to 2,921,111 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/11/26 6:30:02 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Carson Seana was granted 137,922 shares, increasing direct ownership by 28% to 637,507 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/11/26 6:24:17 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Development Officer Pestano Gary Anthony converted options into 1,481 shares and sold $5,445 worth of shares (540 units at $10.08), increasing direct ownership by 11% to 9,387 units (SEC Form 4)

    4 - BIODESIX INC (0001439725) (Issuer)

    2/11/26 6:03:20 PM ET
    $BDSX
    Medical Specialities
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Coinbase Global downgraded by Monness Crespi & Hardt with a new price target

    Monness Crespi & Hardt downgraded Coinbase Global from Buy to Neutral and set a new price target of $120.00

    2/12/26 7:44:13 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    Peloton downgraded by Argus

    Argus downgraded Peloton from Buy to Hold

    2/10/26 7:17:53 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Leerink Partners initiated coverage on Terns Pharmaceuticals with a new price target

    Leerink Partners initiated coverage of Terns Pharmaceuticals with a rating of Outperform and set a new price target of $58.00

    2/9/26 6:54:14 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Terns Pharmaceuticals Inc.

    SCHEDULE 13G - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    2/12/26 9:14:38 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Annovis Bio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Annovis Bio, Inc. (0001477845) (Filer)

    2/12/26 9:00:47 AM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Benitec Biopharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Benitec Biopharma Inc. (0001808898) (Filer)

    2/12/26 8:09:54 AM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Leadership Updates

    Live Leadership Updates

    View All

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Kroger Appoints Greg Foran as Chief Executive Officer

    Accomplished Food Retail Leader Brings Strong Experience as Company Advances Its Growth Strategy Ron Sargent Continues as Chairman of Kroger's Board of Directors  CINCINNATI, Feb. 9, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its Board of Directors appointed Greg Foran as Chief Executive Officer, effective immediately. Foran will also join Kroger's Board of Directors and succeeds Ron Sargent, who served as interim CEO since March 2025. This announcement follows an extensive search process conducted by the Board to identify an innovative retail leader with a strong track record of execution at scale.

    2/9/26 7:30:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form SC 13G filed by Alector Inc.

    SC 13G - Alector, Inc. (0001653087) (Subject)

    12/6/24 5:30:28 PM ET
    $ALEC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AHI
    $AKRO
    $ALEC
    Financials

    Live finance-specific insights

    View All

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    RETRANSMISSION: HIVE Digital Technologies to Release Fiscal Q3 2026 Financial Results and Hold Earnings Call on February 17

    San Antonio, Texas--(Newsfile Corp. - February 12, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), a diversified global leader in renewable-powered blockchain and AI infrastructure, today announced it will release its financial results for the nine months ended December 31, 2025 on Tuesday, February 17, 2026, followed by an earnings conference call and webcast on Tuesday, February 17, 2026, at 8:00 AM EST.Conference Call InformationTo participate in this event, please log on or dial in approximately 5 minutes before the call.Date: February 17, 2026Time: 8:00 AM EST Webcast: Registration link here. Dial-in: Provided after re

    2/12/26 6:00:00 AM ET
    $HIVE
    Finance: Consumer Services
    Finance

    Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    LOUISVILLE, Colo., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NASDAQ:BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025 after the close of trading on Thursday, February 26. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day. Listeners can register for the webcast via this link. Analysts who wish to participate in the question and answer session should use this link. A replay of the webcast will be available via the company's investor website approximately t

    2/12/26 6:00:00 AM ET
    $BDSX
    Medical Specialities
    Health Care